# A Study to Learn About the Study Medicine Called PF-07868489 in Healthy Adult People and in People With Pulmonary Arterial Hypertension

> **NCT06137742** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Pfizer** · enrollment: 97 (actual)

## Conditions studied

- Pulmonary Arterial Hypertension

## Interventions

- **DRUG:** PF-07868489
- **DRUG:** Placebo for PF-07868489

## Key facts

- **NCT ID:** NCT06137742
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-11-17
- **Primary completion:** 2026-09-02
- **Final completion:** 2026-09-02
- **Target enrollment:** 97 (ACTUAL)
- **Last updated:** 2026-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06137742

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06137742, "A Study to Learn About the Study Medicine Called PF-07868489 in Healthy Adult People and in People With Pulmonary Arterial Hypertension". Retrieved via AI Analytics 2026-09-21 from https://api.ai-analytics.org/clinical/NCT06137742. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*